Eli Lilly's big investment, cheaper Zepbound, and what's next for Hims & Hers: Pharma news roundup
Eli Lilly announced plans to invest $27 billion in four new manufacturing sites in the United States. The pharma giant also ...
Verywell Health on MSN1h
Eli Lilly Offers Discounted Zepbound Vials for People Who Pay Out of Pocket
Eli Lilly is now offering four doses of Zepbound in self-administration vials. The lower-cost self-pay option targets people on Medicare and those who can no longer access compounded tirzepatide.
MM&M4h
Faced with compounded drugs, Eli Lilly tells consumers to ‘be a healthy skeptic’
Eli Lilly is seeking to further cement its stance as a leader in weight loss drugs in an ad campaign calling out “unapproved” medications.
Eli Lilly plans to invest $27B to build four new US plants as tariffs loom
Pharmaceutical giant expects the move will create 3,000 high-skilled jobs and provide work for approximately 10,000 ...
Eli Lilly announces $27-billion US expansion: To add 13,000 jobs and new manufacturing sites
Eli Lilly & Co has announced a $27-billion expansion of its US manufacturing operations, adding four new sites and creating ...
Eli Lilly Doubles Capital Spending On US Drug Manufacturing With $50 Billion Target
At a press conference in Washington, D.C., Eli Lilly And Co (NYSE:LLY) announced its plans to bolster its domestic medicine ...
Eli Lilly and Company (LLY): A High Growth Mega Cap Stock You Can Buy and Hold for the Next 5 Years
We recently compiled a list of the 20 High Growth Mega Cap Stocks You Can Buy And Hold For Next 5 Years. In this article, we ...
24/7 Wall St. on MSN4d
HIMS is Out. Is Novo Nordisk or Eli Lilly the Better GLP-1 Buy?
The Food & Drug Administration announced last week that the Ozempic and Wegovy shortage for Novo Nordisk's (NYSE:NVO) was ...